Pietų Afrika - anglų - South African Health Products Regulatory Authority (SAHPRA)

pharma-q holdings (pty) ltd - #n/a - not indicated - none

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bisacodyl 5mg;   - enteric coated tablet - 5 mg - active: bisacodyl 5mg   excipient: acacia carnauba wax castor oil glycerol iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate   maize starch as 8.3mg dried starch and 1.5mg soluble starch methacrylic acid copolymer purified talc shellac sucrose titanium dioxide white beeswax

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bisacodyl 10mg;   - suppository - 10 mg - active: bisacodyl 10mg   excipient: hard fat

Australija - anglų - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olanzapine, quantity: 5 mg - tablet, film coated - excipient ingredients: pectin; mannitol; isopropyl alcohol; hyprolose; purified talc; lactose monohydrate; purified water; triacetin; titanium dioxide; magnesium stearate; propylene glycol; butan-1-ol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - olanzapine is indicated for the treatment of schizophrenia and related psychoses.,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olanzapine, quantity: 10 mg - tablet, film coated - excipient ingredients: purified water; lactose monohydrate; titanium dioxide; isopropyl alcohol; pectin; magnesium stearate; triacetin; hyprolose; purified talc; mannitol; propylene glycol; butan-1-ol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - olanzapine is indicated for the treatment of schizophrenia and related psychoses.,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; triacetin; isopropyl alcohol; pectin; titanium dioxide; magnesium stearate; hyprolose; mannitol; purified talc; purified water; propylene glycol; butan-1-ol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - olanzapine is indicated for the treatment of schizophrenia and related psychoses.,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: purified talc; hyprolose; magnesium stearate; lactose monohydrate; titanium dioxide; mannitol; isopropyl alcohol; pectin; purified water; triacetin; propylene glycol; butan-1-ol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - olanzapine is indicated for the treatment of schizophrenia and related psychoses.,olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.,olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

allergan, inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone acetate 1 mg - minastrin 24 fe is indicated for use by females of reproductive age to prevent pregnancy [ see clinical studies (14) ] .  the efficacy of minastrin 24 fe in women with a body mass index (bmi) of more than 35 kg/m2 has not been evaluated. minastrin 24 fe is contraindicated in females who are known to have or develop the following conditions: - a high risk of arterial or venous thrombotic diseases. examples include women who are known to: • smoke, if over age 35 [see boxed warning and warnings and precautions (5.1) ] • have deep vein thrombosis or pulmonary embolism, now or in the past [see warnings and precautions (5.1) ] • have cerebrovascular disease [see warnings and precautions (5.1) ] • have coronary artery disease [see warnings and precautions (5.1) ]   • have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see warnings and precautions (5.1) ] • have inherited or acquire

Australija - anglų - Department of Health (Therapeutic Goods Administration)

ms health pty ltd - mifepristone, quantity: 200 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; povidone - mifepristone linepharma 200 mg tablet is indicated in females of childbearing age for preparation for the action of registered prostaglandin analogues that are indicated for the termination of pregnancy for medical reasons beyond the first trimester.

Malta - anglų - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftriaxone sodium - powder for solution for infusion - ceftriaxone sodium 2 gram(s) - antibacterials for systemic use